NCT06188325 A Study to Evaluate Pharmacokinetic Parameters of Eliglustat in Healthy Volunteers Who Are CYP2D6 Extensive or Poor Metabolizers Status COMPLETED Phase PHASE1
NCT06181435 A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2) Status COMPLETED Phase PHASE3
NCT06169527 A Long-term Data Collection Study of Participants in France Aged 6 Years Old or More With Atopic Dermatitis Receiving Dupilumab Status ACTIVE_NOT_RECRUITING Phase N/A
NCT06163807 Follow-up of Spanish Prospective Asthma and Nasal Polyposis Registry Status RECRUITING Phase N/A
NCT06159452 Study of the Tolerability of Different SAR153191 Drug Products, That Differ With Respect to Manufacturing Processes and Formulation, at Different Concentrations and Doses in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT06145373 A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab Status RECRUITING Phase PHASE4
NCT06143904 A Study to Evaluate Absolute Bioavailability, Absorption, Metabolism, and Excretion of Genz-112638 in Healthy Male Participants Status COMPLETED Phase PHASE1
NCT06143891 A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease. Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06141486 Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06141473 Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06137261 Screening Adults With Obesity to Reduce Heart Failure Events Status ACTIVE_NOT_RECRUITING Phase NA
NCT06131840 A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT06130566 A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis Status COMPLETED Phase PHASE3
NCT06118099 Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Status TERMINATED Phase PHASE2
NCT06114238 Pharmacokinetic Study to Compare Itepekimab Exposure When Administered With an Autoinjector Versus Prefilled Syringe Status COMPLETED Phase PHASE1
NCT06112132 National Observatory of Children Hospitalized for Acute Respiratory Distress or Lower Respiratory Tract Infections Status COMPLETED Phase N/A
NCT06111586 Frexalimab in Preservation of Endogenous Insulin Secretion Compared to Placebo in Adults, Adolescents and Children on Top of Insulin Therapy (FABULINUS) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06106074 Study of the Tolerability and Pharmacokinetics of Oral Doses of SAR442168 With a Food Effect Investigation in Healthy Adult Participants Status COMPLETED Phase PHASE1
NCT06102005 Dose Ranging Study of Lunsekimig Compared With Placebo-control in Adult Participants With Moderate-to-severe Asthma Status COMPLETED Phase PHASE2
NCT06101095 A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial) Status ACTIVE_NOT_RECRUITING Phase PHASE4